Rosanna Lau

1.3k total citations
18 papers, 436 citations indexed

About

Rosanna Lau is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rosanna Lau has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Rosanna Lau's work include Molecular Biology Techniques and Applications (5 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Rosanna Lau is often cited by papers focused on Molecular Biology Techniques and Applications (5 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Rosanna Lau collaborates with scholars based in United States, Canada and Germany. Rosanna Lau's co-authors include M.A. Christine Pratt, Miguel A. Cabrita, W. Fraser Symmans, Peter A. Crooks, Bruce C. McKay, Emma Nolan, Jane E. Visvader, A. C. SAU, Lajos Pusztai and Christos Hatzis and has published in prestigious journals such as PLoS ONE, Oncogene and Cell stem cell.

In The Last Decade

Rosanna Lau

17 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosanna Lau United States 10 249 175 171 79 65 18 436
Nomeda Girnius United States 9 351 1.4× 129 0.7× 315 1.8× 47 0.6× 54 0.8× 14 573
Anneke Q. van Hoesel Netherlands 12 514 2.1× 208 1.2× 169 1.0× 49 0.6× 77 1.2× 13 651
Chun‐Fui Lai United Kingdom 10 228 0.9× 110 0.6× 151 0.9× 132 1.7× 50 0.8× 13 421
Carla Azzurra Amoreo Italy 15 249 1.0× 148 0.8× 193 1.1× 30 0.4× 45 0.7× 25 492
Laura Guerra Spain 14 183 0.7× 95 0.5× 163 1.0× 66 0.8× 166 2.6× 34 543
Lizhi Zhang United States 10 309 1.2× 104 0.6× 163 1.0× 50 0.6× 84 1.3× 18 474
Alexander C. Jordan United States 7 307 1.2× 87 0.5× 134 0.8× 38 0.5× 46 0.7× 10 453
Shusil K. Pandit Netherlands 7 359 1.4× 86 0.5× 186 1.1× 55 0.7× 45 0.7× 9 546
Guiqin Xu China 12 425 1.7× 133 0.8× 188 1.1× 41 0.5× 78 1.2× 21 559
Tatiana de Almeida Simão Brazil 14 316 1.3× 108 0.6× 115 0.7× 72 0.9× 35 0.5× 28 475

Countries citing papers authored by Rosanna Lau

Since Specialization
Citations

This map shows the geographic impact of Rosanna Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosanna Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosanna Lau more than expected).

Fields of papers citing papers by Rosanna Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosanna Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosanna Lau. The network helps show where Rosanna Lau may publish in the future.

Co-authorship network of co-authors of Rosanna Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Rosanna Lau. A scholar is included among the top collaborators of Rosanna Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosanna Lau. Rosanna Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tran, Kevin, Michał Marczyk, Chunxiao Fu, et al.. (2024). Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomes. Journal of the American Society of Cytopathology. 14(2). 91–101.
2.
Marczyk, Michał, Chunxiao Fu, Rosanna Lau, et al.. (2023). Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing. Cancer Cytopathology. 131(5). 289–299. 4 indexed citations
3.
Tran, Kevin, Chunxiao Fu, Lili Du, et al.. (2022). Molecular testing opportunities on cytology effusion specimens: the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing. Journal of the American Society of Cytopathology. 12(1). 10–19. 5 indexed citations
4.
5.
Bossuyt, Veerle, Rosanna Lau, John Greg Howe, et al.. (2021). Intra- and Interlaboratory Reproducibility of the Sensitivity to Endocrine Therapy Assay for Stage II/III Breast Cancer. Clinical Chemistry. 67(9). 1240–1248. 3 indexed citations
6.
Lau, Rosanna, Lili Du, Eveline Chen, et al.. (2020). Technical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue. Clinical Chemistry. 66(7). 934–945. 7 indexed citations
7.
Marczyk, Michał, Chunxiao Fu, Rosanna Lau, et al.. (2019). The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues. BMC Cancer. 19(1). 1189–1189. 41 indexed citations
9.
Lau, Rosanna, et al.. (2018). cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and Tumorigenesis. Journal of Mammary Gland Biology and Neoplasia. 23(3). 109–123. 6 indexed citations
10.
SAU, A. C., Rosanna Lau, Miguel A. Cabrita, et al.. (2016). Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. Cell stem cell. 19(1). 52–65. 79 indexed citations
11.
Jiang, Tingting, Weiwei Shi, Vikram B. Wali, et al.. (2016). Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis. PLoS Medicine. 13(12). e1002193–e1002193. 57 indexed citations
12.
Lau, Rosanna, Miguel A. Cabrita, Bruce C. McKay, et al.. (2014). Preferential Estrogen Receptor β Ligands Reduce Bcl-2 Expression in Hormone-Resistant Breast Cancer Cells to Increase Autophagy. Molecular Cancer Therapeutics. 13(7). 1882–1893. 45 indexed citations
13.
Brochu, Christian, et al.. (2013). NF-κB-Dependent Role for Cold-Inducible RNA Binding Protein in Regulating Interleukin 1β. PLoS ONE. 8(2). e57426–e57426. 43 indexed citations
14.
Lau, Rosanna & M.A. Christine Pratt. (2012). The Opposing Roles of Cellular Inhibitor of Apoptosis Proteins in Cancer. ISRN Oncology. 2012. 1–5. 23 indexed citations
15.
Lau, Rosanna, Min Niu, & M.A. Christine Pratt. (2012). cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle. 11(21). 4009–4019. 17 indexed citations
16.
Wright, James S., Hooman Shadnia, James Michael Anderson, et al.. (2010). A-CD Estrogens. I. Substituent Effects, Hormone Potency, and Receptor Subtype Selectivity in a New Family of Flexible Estrogenic Compounds. Journal of Medicinal Chemistry. 54(2). 433–448. 21 indexed citations
17.
Pratt, M.A. Christine, et al.. (2009). The canonical NF-κB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene. 28(30). 2710–2722. 59 indexed citations
18.
Lau, Rosanna, Roger Grimson, Christine Sansome, Carmen Tornos, & Ute M. Moll. (2001). Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.. International Journal of Oncology. 18(1). 17–23. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026